About The Position

The Geneva Foundation is recruiting a Post-Doctoral Fellow to join a cutting-edge research team advancing Military Brain Health at USU's Department of Radiology and Bioengineering. This is an embedded role on-site at WRNMMC, co-located with USU at National Support Activity Bethesda. As a nonprofit partner, Geneva receives and administers federal awards for research conducted directly at DoD installations, serving as a dedicated supporter of federal researchers and a trusted partner in military medical research.

The Post-Doctoral Fellow will develop high-sensitivity, quantitative, and multiparametric MR imaging methods to study neurotrauma and mild cognitive impairment, evaluate their reproducibility, and accelerate their clinical translation. The primary focus of this work will leverage the MAGNUS 3T MRI system — a high-performance, head-only scanner developed in collaboration with GE Healthcare — to map global and microstructural brain anatomy. Working alongside a multidisciplinary team of researchers and radiologists, the fellow will receive comprehensive training in advanced MR acquisition, reconstruction, and data processing techniques.

This is a full time position located in Bethesda, MD — embedded on-site at Walter Reed National Military Medical Center (WRNMMC), USU Dept. of Radiology and Bioengineering. Background checks will be administered.

About The Program

Correlating Repetitive Blast Overpressure Exposure with Neuroinflammation and Microstructural Changes Assessed by MRI in a Large Animal Model

This project leverages a large animal BOP model undergoing a series of LLBE to evaluate both structural and functional changes in both in vivo and ex vivo brains of the exposed animal.

Research Focus & Tools

The Post-Doctoral Fellow will be working in a laboratory that utilizes advanced imaging techniques to assess brain changes due to injury or environmental effects, including:

Diffusion Weighted Imaging
Magnetic Resonance Elastography (MRE)
Multi-echo Functional MRI (fMRI)
World-Class Facilities

Access to the Biomedical Research Imaging Center (BRIC) and the 4D Bio3 Center for Biotechnology, features:

3T GE Healthcare MAGNUS (high-gradient, head-only scanner)
7.0T Bruker MRI scanner
Siemens MRI platform
Extensive collaborative networks across military and global academic sectors

Compensation

$75,000 - $88,000. Salaries are determined based on several factors including external market data, internal equity, and the candidate’s related knowledge, skills, and abilities for the position.

Qualifications

PhD (or equivalent) in Biomedical Engineering, Electrical Engineering, Chemistry, Physics, or a related field
1-2 years medical research experience strongly desired
Candidates who have successfully defended their dissertation and graduated from their PhD program are eligible. Degree conferral is not required at the time of hire, but the degree must be completed by the end of the semester in which the dissertation was successfully defended
Strong background in MR physics, data analysis, and computer programming
Preferred experience in pulse sequence programming or image reconstruction
Excellent written and oral communication skills
Ability to excel in both independent research and large-scale collaborative projects
Ability to pass background screening, U.S. work authorization required

Responsibilities

Collaborate and assist the Principle Investigator, Co-Investigators and research team in the performance of the research study
Contribute to the drafting and submitting of abstracts, manuscripts and reports for dissemination
Prepare progress reports on research as required
Analyze and write-up data
Present complex information effectively to a range of audiences
Provide data management assistance
Provide project close-out support

About the company

The Geneva Foundation advances military medicine to improve the health of service members and the communities they serve through research, development, and education. It leverages 30 years of scientific and program-management expertise to support federal grants, federal contracts, industry-sponsored clinical trials, and educational services. It differentiates itself as a 501(c)(3) nonprofit focused specifically on military health and acts as a bridge among service members, researchers, industry sponsors, and healthcare providers. Its goal is to ensure optimal health for service members and communities by turning medical knowledge into practice.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Tacoma, Washington

Founded

1993

Get referred to The Geneva Foundation

See people who can refer or advise you

Simplify's Take

What believers are saying

May 2026 NeuroCatch partnership adds cognitive-health research for warfighter readiness.
April 2026 DHA award brought $488,276 for breast-cancer research through March 2029.
June 2026 RESPOND-US membership expands Geneva into trauma and emergency readiness networks.

What critics are saying

DoD funding concentration makes Geneva hostage to budget shifts and contract renewals.
Research intermediary model depends on external partners like NeuroCatch and Philips for pipeline.
A single federal contract collapse could cripple operations and eliminate mission relevance.

What makes The Geneva Foundation unique

30+ years advancing military medicine through DoD-aligned research and deployment.
Master CRADA with Defense Health Agency streamlines research at military treatment facilities.
Deep portfolio spans AREVA, MIRROR, TSNRP, REC^3^ON, and 4DBio3 programs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Health Savings Account/Flexible Spending Account
Disability Insurance
Life Insurance
Paid Vacation
Paid Holidays
Professional Development Budget

Company News

TMX Newsfile

May 12th, 2026

NeuroCatch Inc. announces strategic partnership with The Geneva Foundation to advance cognitive health research for military personnel.

NeuroCatch Inc. announces strategic partnership with The Geneva Foundation to advance cognitive health research for military personnel. Groundbreaking collaboration supports cutting-edge research to improve brain health assessment for military service members. Vancouver, British Columbia-(Newsfile Corp. - May 12, 2026) - NeuroCatch Inc., a leader in objective cognitive brain health assessment, today announced a research partnership with The Geneva Foundation (Geneva), a nonprofit organization dedicated to advancing military medical research and warfighter readiness. Through this collaboration, NeuroCatch's technology will support innovative research initiatives aimed at improving cognitive health outcomes for military service members. The NeuroCatch Platform is an objective neurophysiological brain function assessment tool that delivers rapid, evidence-based evaluations of cognitive brain health at the point of care in approximately six minutes. Using electroencephalography (EEG) technology, it measures key brain vital signs - including attention, auditory sensation, and cognitive processing - providing clinicians and researchers with precise, actionable data to support informed decision-making and personalized care. Geneva brings extensive expertise in advancing military medical research programs and a strong commitment to warfighter health. This partnership reflects a shared dedication to deploying innovative tools that advance cognitive resilience and performance among military personnel. "We are honored to partner with The Geneva Foundation in advancing research that directly supports our military service members," said Derek Norsworthy, CEO of NeuroCatch Inc. "Objective measurement of brain function is critical to improving how cognitive health is assessed and monitored in high-performance and high-risk environments. We are proud to contribute and look forward to a lasting and growing partnership." "We are excited to partner with NeuroCatch Inc. to bring innovative, objective brain health technologies into military research," said Elise Huszar, President and CEO of The Geneva Foundation. "This collaboration aligns with our mission to advance evidence-based solutions that enhance warfighter readiness and resilience. By integrating cutting-edge technology into our research portfolio, Geneva is better positioned to support the long-term health and performance outcomes of Service members." About the NeuroCatch Platform The NeuroCatch Platform is available for sale in the U.S. It is not intended as a stand-alone or adjunctive diagnostic device and does not identify the presence or absence of clinical diagnoses. The platform is intended to be used in conjunction with other cognitive assessments and is not a diagnostic tool for any specific brain health condition. About The Geneva Foundation Geneva is a mission-driven organization with 30+ years of experience advancing operationally relevant, unique research aligned with military health priorities to strengthen mission success and force readiness. Geneva accelerates military medical research and development into fielded capability, bridging the gap between discovery and deployment to deliver solutions that meet evolving operational demands. With deep expertise in research operations, government contracting, and strategic collaboration, Geneva enables the transition from research investment to measurable operational impact. Peter Romeo Email: [email protected] Phone: 1-844-847-1264 NeuroCatch Inc. Unit 1009, City Centre 3 13761 96 Avenue, Surrey, BC V3V 0E8 Canada Ready to announce with confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

RIVANNA

Sep 8th, 2025

RIVANNA awarded $3 million CDMRP grant to develop military-optimized ultrasound guidance system for spinal interventions

RIVANNA awarded $3 million CDMRP grant to develop military-optimized ultrasound guidance system for spinal interventions.

Kitware

Feb 7th, 2024

Developing AI Algorithms to Assist with Medical Triage

Kitware, in collaboration with Soar Technology and The Geneva Foundation, will develop AI algorithms paired with rule-based symbolic predictions that provide decision support targeted at life-saving interventions for injuries, including hemorrhage, pneumothorax, and airway obstructions.

Yahoo Finance

Oct 24th, 2023

Oref, Mtec, Dod Select Recipients Of $2 Million Research Award Collaboration

Recipients will utilize the funds for research leading to the advancement of solutions to accelerate return-to-readiness for Service Members experiencing musculoskeletal injuries.ROSEMONT, Ill., Oct. 24, 2023 /PRNewswire-PRWeb/ -- The Orthopaedic Research and Education Foundation (OREF), in collaboration with the Medical Technology Enterprise Consortium (MTEC) and the Department of Defense's (DOD) U.S. Army Medical Research and Development Command's (USAMRDC) Military Operational Medicine Research Program (MOMRP), today announced selection for recipients of the OREF/MTEC Request for Project Proposals entitled, "MTEC-23-02-MSKI, Solutions to Accelerate Return-to-Readiness following Musculoskeletal Injuries." The program provides $2 million in research and development funding. OREF is contributing $100,000 toward the awards, which was made possible by a generous gift from The Aircast Foundation, a private foundation committed to promoting and supporting excellence in scientific and clinical research and education in the area of orthopaedic medicine. The remainder of the funding is provided by the DOD.Awards were made to the Henry Jackson Foundation for the Advancement of Military Medicine Inc., which will receive $1.3 million for its study addressing dynamic gait-synchronous neuromuscular electrical stimulation following anterior cruciate ligament (ACL) reconstruction, and the Geneva Foundation, which will receive over $700,000 for its study addressing the development of a dynamic three-dimensional knee assessment medical device to accelerate return to readiness from knee pain. Studies will commence in September 2023, and it is expected that they will conclude no later than September 2026."OREF is committed to improving care and outcomes for all patients, including those serving in our military forces," noted OREF Trustee Colonel James R

Geneva USA

Sep 22nd, 2023

Geneva Leads New $9.8M+ Research Program to Revolutionize Military Musculoskeletal Injury Management

Bethesda, MD - The Geneva Foundation, a leading nonprofit dedicated to advancing military medicine, has received $9.84 million to pioneer a deployment-limiting musculoskeletal conditions (DLMC) research program.

The Geneva Foundation

Postdoctoral Fellow: Neuroimaging & Military Brain Health

About the job